General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0DLMBC
ADC Name
RG-7986
Synonyms
RG7986; RG 7986
   Click to Show/Hide
Organization
Genentech, Inc.; Roche Holding AG; Seagen Inc.
Drug Status
Terminated in phase 1
Indication
In total 1 Indication(s)
Non Hodgkin lymphoma [ICD11:2B33]
Terminated in phase 1
Antibody Name
Undisclosed
Antigen Name
Undisclosed
Payload Name
Undisclosed
Linker Name
Undisclosed

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.